Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Glanzmann's Thrombasthenia: A Prospective Observational Registry

NCT01476423 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01476423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01476423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Glanzmann's Thrombasthenia: A Prospective Observational Registry
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
January 31, 2004
Completion date
October 31, 2011
Enrollment
218 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, glanzmann's disease